Liver metastases lead to resistance to immunotherapy through the ‘siphoning’ of tumor antigen–specific CD8+ T cells into the liver, which results in a systemic ‘immune desert’ incapable of controlling tumor burden.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
New clinical trial design in precision medicine: discovery, development and direction
Signal Transduction and Targeted Therapy Open Access 04 March 2024
-
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial
Frontiers of Medicine Open Access 04 July 2023
-
Establishment of a rabbit liver metastasis model by percutaneous puncture of the spleen and implantation of the VX2 tumor strain under CT guidance
Scientific Reports Open Access 16 February 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Cell 168, 707–723 (2017).
Yu, J. et al. Nat. Med. https://doi.org/10.1038/s41591-020-1131-x (2020).
Forrester, J. V., Xu, H., Lambe, T. & Cornall, R. Mucosal Immunol. 1, 372–381 (2008).
Medina-Echeverz, J., Eggert, T., Han, M. & Greten, T. F. Cancer Immunol. Immunother. 64, 931–940 (2015).
Qian, B. Z. & Pollard, J. W. Cell 141, 39–51 (2010).
Twyman-Saint Victor, C. et al. Nature 520, 373–377 (2015).
Lee, J. C. et al. Sci. Immunol. 5, eaba0759 (2020).
Finn, R. S. et al. N. Engl. J. Med. 382, 1894–1905 (2020).
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. & Allavena, P. Nat. Rev. Clin. Oncol. 14, 399–416 (2017).
Villanueva, A. N. Engl. J. Med. 380, 1450–1462 (2019).
Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E. & Heikenwalder, M. Nat. Immunol. 19, 222–232 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Lindblad, K.E., Lujambio, A. Liver metastases inhibit immunotherapy efficacy. Nat Med 27, 25–27 (2021). https://doi.org/10.1038/s41591-020-01190-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-020-01190-9
This article is cited by
-
New clinical trial design in precision medicine: discovery, development and direction
Signal Transduction and Targeted Therapy (2024)
-
Establishment of a rabbit liver metastasis model by percutaneous puncture of the spleen and implantation of the VX2 tumor strain under CT guidance
Scientific Reports (2023)
-
Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients
Journal of Cancer Research and Clinical Oncology (2023)
-
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis
Clinical & Experimental Metastasis (2023)
-
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial
Frontiers of Medicine (2023)
